Madam Speaker, in recent months, researchers have created apparent embryonic stem cells from reprogrammed adult skin cells.

This exciting breakthrough, known as induced pluripotent stem cells or iPS, is an important milestone.  However, it should not halt our efforts towards embryonic stem cell research.

The iPS method is still in its earliest stages, and there is widespread debate among the scientific community as to the safety and effectiveness of its practical application.

Embryonic stem cell research remains the gold standard for potential therapeutic use.  Further, it has laid a foundation of scientific knowledge that made these recent discoveries possible.

We should not abandon one area of research just because we have made progress in another.  We must continue our investment, both public and private, into all areas of responsible stem cell research.  The hope of millions of Americans depends on it.

I thank you and yield back.